Initial results suggested that the peptide might have contributed to increased body mass and possibly to higher bone mineral content (BMC) in the tibia and vertebrae, as indicated by DEXA measurements, compared to those in the control group
Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons
Other common side effects include: Dizziness and lightheadedness, particularly during the first few weeks Fatigue and low energy , often related to reduced caloric intake Headaches , which typically resolve within the first month Sulfur burps , a distinctive and common complaint Diarrhea , which usually resolves as the body adjusts Injection site reactions including redness and mild swelling Less common but important considerations Some patients experience hair loss on GLP-1 medications
Month 2-3: Clear improvements Physical changes: Fine lines visibly reduced Skin texture significantly improved Better collagen density (skin feels thicker, more resilient) Improved elasticity Reduced redness or uneven tone What photos show: Side-by-side comparison reveals obvious improvements
The platform eliminates the need for in-person appointments, pharmacy visits, or traditional insurance authorization processes
Weight loss drugs could have cardiovascular benefits, new research shows New research has revealed that semaglutide, the active ingredient in weight loss jabs such as Wegovy and Ozempic, could reduce a persons risk of dangerous heart events such as a heart attack and stroke, regardless of the amount of weight lost
